RYAN STEPHEN J 4

Accession 0001127602-12-024001

CIK 0000850693other

View on SEC.gov Company Profile

Filed

Aug 6, 8:00 PM ET

Accepted

Aug 7, 8:58 PM ET

Size

33.7 KB

Accession

0001127602-12-024001

Insider Transaction Report

Form 4

Period: 2012-08-03

ALLERGAN INCAGN

RYAN STEPHEN J

Director

Transactions

Exercise/Conversion
Common Stock
2012-08-03$36.85/sh+5,000$184,250→ 53,451.819 total
Exercise/Conversion
Common Stock
2012-08-03$36.49/sh+5,000$182,450→ 63,451.819 total
Sale
Common Stock
2012-08-03$86.50/sh−15,000$1,297,556→ 48,451.819 total
Exercise/Conversion
Common Stock
2012-08-06$51.72/sh+9,000$465,435→ 57,451.819 total
Exercise/Conversion
Common Stock
2012-08-06$54.32/sh+6,900$374,808→ 64,351.819 total
Sale
Common Stock
2012-08-06$85.47/sh−15,900$1,358,928→ 48,451.819 total
Exercise/Conversion
Common Stock
2012-08-07$54.32/sh+4,500$244,440→ 52,951.819 total
Exercise/Conversion
Common Stock
2012-08-07$46.66/sh+11,400$531,924→ 64,351.819 total
Sale
Common Stock
2012-08-07$85.35/sh−15,900$1,356,989→ 48,451.819 total
Exercise/Conversion
Nonemployee Director Stock Option (Right to Buy)
2012-08-03−5,000→ 0 total
Exercise: $36.85From: 2004-04-25Exp: 2013-04-24→ Common Stock (5,000 underlying)
Exercise/Conversion
Nonemployee Director Stock Option (Right to Buy)
2012-08-03−5,000→ 0 total
Exercise: $45.88From: 2005-04-28Exp: 2014-04-28→ Common Stock (5,000 underlying)
Exercise/Conversion
Nonemployee Director Stock Option (Right to Buy)
2012-08-03−5,000→ 0 total
Exercise: $36.49From: 2006-04-26Exp: 2015-04-26→ Common Stock (5,000 underlying)
Exercise/Conversion
Nonemployee Director Stock Option (Right to Buy)
2012-08-06−6,900→ 4,500 total
Exercise: $54.32Exp: 2018-05-06→ Common Stock (6,900 underlying)
Exercise/Conversion
Common Stock
2012-08-03$45.88/sh+5,000$229,425→ 58,451.819 total
Exercise/Conversion
Nonemployee Director Stock Option (Right to Buy)
2012-08-06−9,000→ 0 total
Exercise: $51.71From: 2007-05-02Exp: 2016-05-02→ Common Stock (9,000 underlying)
Exercise/Conversion
Nonemployee Director Stock Option (Right to Buy)
2012-08-07−4,500→ 0 total
Exercise: $54.32Exp: 2018-05-06→ Common Stock (4,500 underlying)
Exercise/Conversion
Nonemployee Director Stock Option (Right to Buy)
2012-08-07−11,400→ 0 total
Exercise: $46.66Exp: 2019-04-30→ Common Stock (11,400 underlying)

Footnotes (5)

[F1]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $86.4375 to $86.5700, inclusive. The reporting person undertakes to provide Allergan, Inc., any securities holder of Allergan, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
[F2]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $85.1500 to $85.6100, inclusive. The reporting person undertakes to provide Allergan, Inc., any securities holder of Allergan, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
[F3]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $85.0700 to $85.6700, inclusive. The reporting person undertakes to provide Allergan, Inc., any securities holder of Allergan, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
[F4]Option is fully vested and exercisable upon the earlier to occur (i) the first anniversary of the grant date, or (ii) the annual meeting held during such calendar year at which one or more members of the board are standing for re-election following the date of grant.
[F5]Option is fully vested and exercisable upon the earlier to occur (i) the first anniversary of the grant date, or (ii) the annual meeting held during such calendar year at which one or more members of the board are standing for re-election following the date of grant.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

ALLERGAN INC

CIK 0000850693

→

Entity typeother

Related Parties

filerCIK 0001190632

Filing Metadata

Form type: 4
Filed: Aug 6, 8:00 PM ET
Accepted: Aug 7, 8:58 PM ET
Size: 33.7 KB

View on SEC.gov